Cannabis use is common among cancer patients, but relatively little is known about the usage patterns and efficacy of cannabis used by gynecologic cancer patients. A recent review collected the demographic and clinical data for gynecologic cancer patients prescribed medical cannabis at New York University Langone Health between May 2016 and February 2019. Formulation prescribed, usage patterns, length of use, symptom relief, and side effect profile were collected from electronic medical records.
Nearly 90% of the 45 gynecologic cancer patients received chemotherapy and 56% were undergoing primary treatment. Medical cannabis was used for an average of 5.2 months. Over 70% of patients reported improvement in nausea/vomiting and 36% of patients reported improvement in pain relief. Of 41 patients with follow-up information, 71% found that cannabis improved at least one symptom.
- Fehniger, J., Brodsky, A. L., Kim, A. & Pothuri, B. Medical marijuana utilization in gynecologic cancer patients. Gynecol Oncol Rep 37, 100820 (2021).